MX9802730A - Multi-functional hematopoietic receptor agonists. - Google Patents

Multi-functional hematopoietic receptor agonists.

Info

Publication number
MX9802730A
MX9802730A MX9802730A MX9802730A MX9802730A MX 9802730 A MX9802730 A MX 9802730A MX 9802730 A MX9802730 A MX 9802730A MX 9802730 A MX9802730 A MX 9802730A MX 9802730 A MX9802730 A MX 9802730A
Authority
MX
Mexico
Prior art keywords
receptor agonists
hematopoietic receptor
functional hematopoietic
proteins
functional
Prior art date
Application number
MX9802730A
Other languages
Spanish (es)
Inventor
Yioing Feng
Nicholas R Staten
Charles M Baum
Neena L Summers
Maire H Caparon
S C Bauer
Linda Zurfluh
John P Mckearn
Barbara Kure Klein
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of MX9802730A publication Critical patent/MX9802730A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/524Thrombopoietin, i.e. C-MPL ligand
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5403IL-3
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Disclosed are novel multi-functional hematopoietic receptor agonist proteins, DNAs which encode the multi-functional hematopoietic receptor agonists proteins, methods of making the multi-functional hematopoietic receptor agonists proteins and methods of using the multi-functional hematopoietic receptor agonists proteins.
MX9802730A 1995-10-05 1998-04-06 Multi-functional hematopoietic receptor agonists. MX9802730A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US483495P 1995-10-05 1995-10-05

Publications (1)

Publication Number Publication Date
MX9802730A true MX9802730A (en) 1998-09-30

Family

ID=21712756

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9802730A MX9802730A (en) 1995-10-05 1998-04-06 Multi-functional hematopoietic receptor agonists.

Country Status (14)

Country Link
EP (1) EP0854928A2 (en)
JP (1) JPH11510062A (en)
KR (1) KR100456212B1 (en)
CN (2) CN1124348C (en)
AU (1) AU705083B2 (en)
BR (1) BRPI9610977A2 (en)
CA (1) CA2234061A1 (en)
CZ (1) CZ295518B6 (en)
IL (1) IL123832A0 (en)
MX (1) MX9802730A (en)
NO (1) NO981500L (en)
NZ (1) NZ320978A (en)
PL (1) PL184424B1 (en)
WO (1) WO1997012985A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US6660257B1 (en) 1996-10-25 2003-12-09 Pharmacia Corporation Circular permuteins of flt3 ligand
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US5969105A (en) * 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
US6187564B1 (en) 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
US6242570B1 (en) 1997-07-10 2001-06-05 Beth Israel Deaconess Medical Center Production and use of recombinant protein multimers with increased biological activity
US6165476A (en) * 1997-07-10 2000-12-26 Beth Israel Deaconess Medical Center Fusion proteins with an immunoglobulin hinge region linker
AU7825500A (en) * 1999-10-07 2001-04-23 Pharmacia Corporation Inhibition enzyme linked immunosorbent assay (iELISA) for the detection and quantification of antibodies in biological samples
JP4444652B2 (en) 2001-07-11 2010-03-31 マキシゲン・ホールディングズ・リミテッド G-CSF conjugate
EP1888119B1 (en) 2005-06-01 2011-03-09 Maxygen, Inc. Pegylated g-csf polypeptides and methods of producing same
WO2007075899A2 (en) * 2005-12-21 2007-07-05 Maxygen, Inc. Dual agonist compounds and uses thereof
CN102675472B (en) * 2012-05-07 2014-07-30 北京诺派生物科技有限公司 Kit for detecting pig suffering from porcine reproductive and respiratory syndrome
ES2896354T3 (en) * 2012-12-21 2022-02-24 Astellas Inst For Regenerative Medicine Methods for the production of platelets from pluripotent stem cells
LT6161B (en) 2013-09-27 2015-06-25 Uab Profarma Fused proteins of granulocyte colony-stimulating factor with other partners of growh factor, preferably with stem cell factor, and method of preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Also Published As

Publication number Publication date
CN1124348C (en) 2003-10-15
KR19990064068A (en) 1999-07-26
NO981500D0 (en) 1998-04-02
NZ320978A (en) 2001-03-30
AU705083B2 (en) 1999-05-13
IL123832A0 (en) 1998-10-30
JPH11510062A (en) 1999-09-07
CZ295518B6 (en) 2005-08-17
PL184424B1 (en) 2002-10-31
EP0854928A2 (en) 1998-07-29
KR100456212B1 (en) 2005-01-15
AU7384496A (en) 1997-04-28
CN1204369A (en) 1999-01-06
WO1997012985A3 (en) 1997-08-07
NO981500L (en) 1998-05-20
WO1997012985A2 (en) 1997-04-10
CA2234061A1 (en) 1997-04-10
CN1590407A (en) 2005-03-09
CZ96598A3 (en) 1998-09-16
PL326072A1 (en) 1998-08-17
BRPI9610977A2 (en) 2019-09-17

Similar Documents

Publication Publication Date Title
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
MX9802730A (en) Multi-functional hematopoietic receptor agonists.
AU9386398A (en) Cysteine rich receptors: trail
MX9707021A (en) Il-17 receptor.
IL132496A0 (en) Mammalian cytokine-like factor 7
EP1117692A4 (en) Tie2 agonist antibodies
LU91758I9 (en)
DE69632949D1 (en) THE ACTIVATION OF RECEPTORS BY GAS6
WO1999000410A3 (en) Human extracellular matrix proteins
WO1998017810A3 (en) Multi-functional chimeric hematopoietic receptor agonists
SI0736525T1 (en) Benzonitriles as 5-HT agonists and antagonists
BR9714355A (en) New flt3 receptor agonists
IL145689A0 (en) Methods
WO2000015798A3 (en) Mammalian transforming growth factor beta - 9 (ztgfss9)
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
AU2813297A (en) Mammalian mixed lymphocyte receptors, chemokine receptors {mmlr-ccr}
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AU9512298A (en) Beta3-adrenoreceptor agonists, agonist compositions and methods of using
EP0929299A4 (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS
AU4178497A (en) HTm4, methods of treatment and assays, agonists and antagonists
PE20399A1 (en) MUTEINA OB
AU1771799A (en) Acetyl-coa-carboxylase from candida albicans
AU3416995A (en) Endothelin receptor antagonists
MX9701904A (en) Novel pka-binding proteins and uses thereof.
MX9802380A (en) SHORT FORMS OF CHEMOKINE 'beta'-8

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees